Clinical Trial Update: IM-862 in Treating Patients With Recurrent Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating IM-862 in patients with recurrent ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• IM-862

Snippet

Sponsor: University of Southern California | Conditions: Ovarian Cancer | Phase 1 | Status: COMPLETED